Aulos Bioscience Appoints Leo Redmond as Chief Financial Officer
News provided by
Share this article
Share this article
LARKSPUR, Calif., May 17, 2021 /PRNewswire/ Aulos Bioscience, a biotechnology company developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors, announced today that Leo Redmond will join the company as chief financial officer. Redmond brings to Aulos nearly three decades of financial experience in the biopharmaceutical industry. He will be based in the company s new headquarters in Larkspur, California. We are pleased to welcome Leo to Aulos at a time when we are rapidly building out our operations in California, preparing to start our first human trial of AU-007, planning our next fundraising scenarios, and defining the corporate strategy. Leo is a wonderful addition to our leadership team. His knowledge and expertise in leading all aspects of financial management for both private and public bi
California
United-states
Anderson-school
Cleo-redmond
Aron-knickerbocker
University-of-kansas
Genentech
Presidio-pharmaceuticals
Aulos-bioscience-inc
Genentech-foundation-for-biomedical-sciences
Anderson-school-of-management
Genentech-foundation
Aulos Bioscience Appoints Aron Knickerbocker as CEO
News provided by
Share this article
Share this article
BOSTON and TEL AVIV, Israel, March 15, 2021 /PRNewswire/ Aulos Bioscience, a biotechnology company that is developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors, announced today that Aron Knickerbocker has joined the company as its chief executive officer and a member of its board of directors, effective immediately. Yanay Ofran, Ph.D., CEO of Biolojic Design and co-founder and founding CEO of Aulos, will continue to serve on the Aulos board.
Aulos was formed late last year by ATP, a leading life sciences venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies. With the addition of Aron Knickerbocker as CEO, we are building a world-class organization with deep experience in bringing breakthrough medicines to cancer patients. Aron s record of ac
Boston
Massachusetts
United-states
Israel
Michael-ehlers
Aron-knickerbocker
Yanay-ofran
Genentech
Aulos-bioscience-inc
Biolojic-design
Five-prime-therapeutics
Five-prime